JPRN-jRCTs041220021招募中1 期
An Exploratory Study to Evaluate the Efficacy and Safety of a Cisplatin Metabolism-Related Enzyme Inhibitor in Cisplatin-Induced Nephrotoxicity
Kondo Masashi0 个研究点目标入组 21 人开始时间: 2022年5月25日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Has provided written consent for participation
- •- Age 20 or greater at the time of consent
- •- Has never received cisplatin-containing chemotherapy
- •- Scheduled for chemotherapy with cisplatin only or cisplatin plus other anticancer agents under hospitalization
- •- Lung, head and neck, and other cancer patients scheduled for cisplatin regimens with doses of 80 mg/m2 or higher in patients with
排除标准
- •- Presence of renal dysfunction: eGFR<60 mL/min/1.73 m2
- •- Pregnant or possibly pregnant women
- •- Lactating women
- •- With a history of hypersensitivity to flopropione
- •- Deemed ineligible for the study as determined by the principal investigator or a co-investigator
研究者
相似试验
招募中
Unknown
Exploratory study of CLZ-BM3D in patients with peripheral occlusive arterial diseasePatients with peripheral occlusive arterial diseaseJPRN-jRCT2072220114akamura Masato24
进行中（未招募）
1 期
Reseach study that will evaluate the efficacy and safety of Bilastine in reducing itching in patients with chronic spontaneous urticaria and other skin diseases.Chronic spontaneous urticaria and the following skin disorders:1 - Eczema/dermatitis (acute eczema, chronic eczema, contact dermatitis, atopic dermatitis, nummular eczema, autosensitisation dermatitis, dyshidrotic eczema, asteatotic eczema, lichen simplex chronicus).2 - Prurigo (acute prurigo, subacute prurigo, chronic prurigo).3 - Cutaneous pruritus (systemic cutaneous pruritus, local cutaneous pruritus).MedDRA version: 19.0Level: HLTClassification code 10012435Term: Dermatitis and eczemaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 19.0Level: PTClassification code 10037083Term: PrurigoSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 19.0Level: PTClassification code 10052568Term: Urticaria chronicSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2016-001505-17-ESFAES FARMA, S.A.115
进行中（未招募）
1 期
Reseach study that will evaluate the efficacy and safety of Bilastine in reducing itching in patients with chronic spontaneous urticaria and other skin diseases.EUCTR2016-001505-17-HUFAES FARMA, S.A.115
招募中
2 期
Exploratory study to investigate the efficacy of a novel mucosal protection method for oral mucositisOral mucositisMucous membrane disorderK123JPRN-jRCTs062220084Omori Kazuhiro30
招募中
2 期
A Expoloratory Study to evaluate the Efficacy and Safety of Hydrocortisone for the Prevention of Symptomatic Vasospasm after Subarachnoid Hemorrhage.Patients with subarachnoid hemorrhage due to cerebral aneurysm rupturesubarachnoid hemorrhage, symptomatic vasospasm, hydrocortisoneJPRN-jRCTs051230153ozumi Yoichi100